4530.T
HISAMITSU PHARMACEUTICAL CO.,INC.
プライム · 医薬品 · 医薬品 · JP
JPY 6,040.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +4.5%
- EBITDA
- —
- EBIT
- -5.2%
- EPS
- -9.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +1.2%
- EBITDA
- —
- EPS
- +14.0%
Three-year CAGR
- Revenue
- +8.3%
- EBITDA
- +14.5%
- EBIT
- +15.6%
- Net income
- +17.7%
- EPS
- +22.0%
- Free cash flow
- +24.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Feb 1, 2026